Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?
AME Med J
.
2018 Feb:3:27.
doi: 10.21037/amj.2018.02.01.
Epub 2018 Feb 10.
Authors
Kali Zhou
1
,
Norah Terrault
1
Affiliation
1
Department of Gastroenterology/Hepatology, University of California, San Francisco, San Francisco, CA, USA.
PMID:
31058256
PMCID:
PMC6497398
DOI:
10.21037/amj.2018.02.01
No abstract available
Publication types
Comment
Grants and funding
T32 DK060414/DK/NIDDK NIH HHS/United States